EVO 4.29 (+1.42%)
US30050E1055Drug ManufacturersDrug Manufacturers - Specialty & Generic

Evotec (EVO) Competitor Comparison

We are evaluating the key criteria listed to compare Evotec (EVO) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - EVO ranking 0 / 54

These are the competitors of Evotec in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Evolus EOLS
54.18
2. Alvotech ALVO
15.66
3. ProPhase Labs PRPH
14.25
4. Theratechnologies THTX
13.98
5. Eagle Pharmaceuticals EGRX
9.12
6. Alimera Sciences ALIM
7.61
7. Vifor Pharma G2AB.F
7.23
8. Green Thumb Industries R9U2.F
6.96
9. Cumberland Pharmaceuticals CPIX
5.55
10. PetIQ PETQ
5.4
11. Linc LNC
4.88
12. Kolinpharma KIP.MI
4.84
13. Phibro Animal Health PAHC
4.48
14. Organogenesis Holdings ORGO
4.32
15. Emergent BioSolutions EBS
4.16
16. ANI Pharmaceuticals ANIP
4.05
17. Kamada KMDA
3.8
18. Amphastar Pharmaceuticals AMPH
3.79
19. Journey Medical DERM
3.78
20. Societal CDMO SCTL
3.72
21. Ayr Wellness 3KJB.F
3.68
22. Avadel Pharmaceuticals AVDL
3.46
23. Curaleaf Holdings CURLF
3.36
24. Pacira BioSciences PCRX
2.89
25. Taro Pharmaceutical Industries TARO
2.87
26. Ironwood Pharmaceuticals IRWD
2.86
27. Elanco Animal Health ELAN
2.76
28. Amneal Pharmaceuticals AMRX
2.76
29. Cronos Group CRON
2.58
30. Procaps Group PROC
2.57
31. Embecta EMBC
2.4
32. Neoleukin Therapeutics NLTX
2.29
33. Tilray Brands TLRY
2.27
34. Catalent CTLT
2.12
35. Supernus Pharmaceuticals SUPN
2.08
36. Teva Pharmaceutical Industries TEVA
1.94
37. Alpha Teknova TKNO
1.85
38. Jupiter Wellness JUPW
1.84
39. Collegium Pharmaceutical COLL
1.8
40. Biofrontera BFRI
1.78
41. Flora Growth FLGC
1.77
42. Ascend Wellness Holdings AAWH
1.76
43. Perrigo PRGO
1.74
44. OptiNose OPTN
1.72
45. Zynerba Pharmaceuticals ZYNE
1.63
46. Clever Leaves Holdings CLVR
1.62
47. Universe Pharmaceuticals UPC
1.58
48. Solid Biosciences SLDB
1.57
49. Relmada Therapeutics RLMD
1.55
50. SCYNEXIS SCYX
1.37
51. Bausch Health Companies BHC
1.28
52. Zoetis ZTS
1.23
53. Regencell Bioscience Holdings RGC
0.83
54. Harrow Health HROW
0.49

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.